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Abstract 
Purpose: The prevalence of subclinical hypothyroidism (SH) is more frequent in 
females than males. Therefore, the aim of this thesis was to evaluate for the first time 
the association of reproductive factors, particularly age at menarche, with SH risk.  
Methods: In a retrospective case-control study, reproductive factors, such as age at 
menarche, age at menopause and at first birth, lactation, parity, full-term pregnancies, 
reproductive years, use of oral contraceptives and hormonal replacement therapy, 
somatometric data, insulin resistance and lipid parameters were recorded in 72 
consecutive female patients with SH and 72 healthy female controls matched on age 
(± 5 years) and date of diagnosis (± 1 month). 
Results: SH cases exhibited significantly younger age at menarche than controls 
(p<0.001). Cases exhibited later age at first pregnancy with a lower number of full-
term pregnancies (p=0.04). Other reproductive factors were similar between cases and 
controls (p>0.05). Early age at menarche was independently associated with SH risk, 
above and beyond age, date of diagnosis, BMI, thyroid autoimmunity, hip 
circumference, HOMA-IR and alcohol consumption (p<0.001, OR: 0.22, 95% CI: 
0.11 – 0.44).  
Conclusion: It seems that an interplay of early exposure to estrogens, as expressed by 
early menarche, and induction of thyroid autoimmunity are associated with SH risk. 
More prospective studies shedding light on the role of estrogens in SH are required to 
confirm these findings.  
Key words: autoimmunity; estrogen; hypothyroidism; menarche; reproductive; 
subclinical; thyroid;  
Institutional Repository - Library & Information Centre - University of Thessaly
04/06/2020 22:21:32 EEST - 137.108.70.13
[2] 
 
«Αναπαραγωγικοί Παράγοντεσ και Υποκλινικόσ 
Υποθυρεοειδιςμόσ: Μελέτη Αςθενών-Μαρτύρων» 
 
ΠΕΡΙΛΗΨΗ 
 
Ειζαγωγή: Ο επηπνιαζκόο ηνπ ππνθιηληθνύ ππνζπξενεηδηζκνύ είλαη ζπρλόηεξνο 
ζηηο γπλαίθεο από όηη ζηνπο άληξεο. Ωο εθ ηνύηνπ, ν ζηόρνο απηήο ηεο δηπιωκαηηθήο 
εξγαζίαο ήηαλ λα αμηνινγεζεί, γηα πξώηε θνξά, ε ζπζρέηηζε ηωλ αλαπαξαγωγηθώλ 
παξαγόληωλ, ηδηαίηεξα ηεο ειηθίαο εκκελαξρήο, κε ηνλ θίλδπλν αλάπηπμεο 
ππνθιηληθνύ ππνζπξενεηδηζκνύ. 
Υλικό και μέθοδοι: Σην πιαίζην κηαο αλαδξνκηθήο κειέηεο ηύπνπ αζζελώλ-
καξηύξωλ κειεηήζεθαλ νη αλαπαξαγωγηθνί παξάγνληεο όπωο: ειηθία εκκελαξρήο, 
ειηθία εκκελόπαπζεο, ειηθία θαηά ηνλ πξώην ηνθεηό, γαινπρία, ηεθλνπνίεζε, 
αξηζκόο ηειεηόκελωλ θπήζεωλ, αλαπαξαγωγηθά έηε, ρξήζε αληηζπιιεπηηθώλ θαη 
ζεξαπεία νξκνληθήο ππνθαηάζηαζεο, ζωκαηνκεηξηθά δεδνκέλα, ηλζνπιηλναληίζηαζε 
θαη ιηπηδαηκηθνί παξάγνληεο ζε 72 δηαδνρηθέο γπλαίθεο αζζελείο κε ππνθιηληθό 
ππνζπξενεηδηζκό θαη 72 πγηείο γπλαίθεο κάξηπξεο εμνκνηωκέλεο ωο πξνο ηελ ειηθία 
(± 5 ρξόληα) θαη ηελ εκεξνκελία δηάγλωζεο (± 1 κήλαο) κε ηηο αζζελείο.  
Αποηελέζμαηα: Οη αζζελείο εκθάληζαλ ζεκαληηθά κηθξόηεξε ειηθία εκκελαξρήο 
από ηηο κάξηπξεο (p<0.001). Επίζεο νη αζζελείο εκθάληζαλ κεγαιύηεξε ειηθία θαηά 
ην πξώην ηνθεηό κε κηθξόηεξν αξηζκό ηειεηόκελωλ θπήζεωλ (p=0.04). Οη ππόινηπνη 
αλαπαξαγωγηθνί παξάγνληεο ήηαλ παξόκνηνη κεηαμύ αζζελώλ θαη καξηύξωλ. Η 
πξώηκε ειηθία εκκελαξρήο ζπζρεηίζηεθε αλεμάξηεηα κε ηνλ ππνθιηληθό 
ππνζπξενεηδηζκό κεηά από ακνηβαίν έιεγρν γηα ηνπο παξάγνληεο εμνκνίωζεο 
(ειηθία θαη εκεξνκελία δηάγλωζεο), ηνλ δείθηε κάδαο ζώκαηνο, ηελ παξνπζία 
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ζπξενεηδηθήο απηναλνζίαο, ηελ πεξηθέξεηα ηζρίωλ, ηνλ δείθηε HOMA-IR θαη ηελ 
θαηαλάιωζε αιθνόι (p<0.001, OR: 0.22, 95% CI: 0.11 – 0.44).  
΢ςμπεπάζμαηα: Ελδέρεηαη ε αιιειεπίδξαζε ηεο πξώηκεο έθζεζεο ζηα νηζηξνγόλα, 
όπωο εθθξάδεηαη από ηελ πξώηκε εκκελαξρή, θαη ηεο ζπξενεηδηθήο απηναλνζίαο λα 
ζπζρεηίδεηαη κε ηνλ θίλδπλν αλάπηπμεο ππνθιηληθνύ ππνζπξενεηδηζκνύ. 
Απαηηνύληαη πεξηζζόηεξεο πξννπηηθέο κειέηεο, νη νπνίεο λα απνζαθελίδνπλ ηνλ 
ξόιν ηωλ νηζηξνγόλωλ ζηνλ ππνθιηληθό ππνζπξενεηδηζκό, γηα λα επηβεβαηώζνπλ ηα 
παξαπάλω επξήκαηα.  
 
Λέξειρ κλειδιά: Αλαπαξαγωγή, Απηναλνζία, Εκκελαξρή, Θπξενεηδήο Αδέλαο, 
Οηζηξνγόλα, Υπνθιηληθόο, Υπνζπξενεηδηζκόο   
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List of abbreviations:  
anti-TG: anti-thyroglobulin antibodies; anti-TPO: anti-peroxidase antibodies; BMI: 
Body Mass Index; BP: blood pressure; CI; Confidence Interval; CVD: Cardiovascular 
Disease; DBP: Diastolic Blood Pressure; DM: Diabetes Mellitus; HDL-C: High-
density lipoprotein cholesterol; HOMA: Homeostasis model assessment score of 
insulin resistance; HT: Hashimoto’s thyroiditis;  HC: hip circumference; HRT: 
Hormone Replacement Therapy; LDL-C: Low-density lipoprotein cholesterol; OR: 
Odds Ratio; SBP: Systolic Blood Pressure; SD: standard deviation; SH: Subclinical 
Hypothyroidism; SLE: Systemic Lupus Erythematosus; T3: Triiodothyronine; T4: 
Thyroxine; TG: Thyroglobulin; TPO: Thyroid peroxidase; TSH: Thyroid stimulating 
hormone; US: ultrasonography; WHR: Waist-to-hip ratio; WC: waist circumference;  
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Introduction 
Subclinical hypothyroidism (SH) is considered a mild thyroid dysfunction which can 
be diagnosed from elevated thyrotropin levels (TSH) in the presence of normal free 
T3 and T4 levels [1]. A significant percentage of patients are asymptomatic while 
others present with weight gain, muscle weakness, fatigue, depression, cold 
intolerance and constipation. SH has also been linked to cardiovascular disease, 
particularly when TSH levels are above 10mIU per liter, metabolic syndrome, 
atherosclerosis, dyslipidemia, diabetes mellitus (DM) type 2 and hypertension [2-5].  
Prevalence of SH is more common in women in midlife with a tendency to increase 
over the age of 50 years. Hashimoto's thyroiditis (HT) is considered the most frequent 
determinant of progressive thyroid dysfunction and SH in adults. In such cases, when 
thyroperoxidase or thyroglobulin antibodies are not easily detected, thyroid 
ultrasonography is performed in order to evaluate thyroid damage [3].    
There are few established risk factors for SH, with thyroid autoimmunity being the 
most important [6]. Because SH is more frequent in women, with a female to male 
ratio of approximately 5 to 1 in the general population, reproductive, menstrual and 
hormonal parameters, particularly age at menarche, may be of paramount importance 
[7,14]. The aim of the present thesis was to explore the potential role of hormonal and 
reproductive factors, particularly age at menarche, in SH risk among women living in 
the Metropolitan region of Attica.  
Materials and Methods 
The study enrolled 72 women suffering from SH and 72 women as healthy control 
participants matched on age and date of diagnosis with cases, between February 2012 
and December 2016 inclusive. All women were of Greek nationality and same 
residency area (Metropolitan area of Athens & Attica region, Greece). This area is 
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considered iodine-sufficient. Medical records were retrieved from the medical records 
of Theodora Stratigou, MD, PhD, consultant Endocrinologist at the Endocrinology 
Department of Evangelismos Hospital. All medical records were reviewed and 
interviews were performed by the same physician (TS), in order to obtain information 
on demographic characteristics, medical history, consumption of coffee and alcoholic 
beverages, tobacco smoking and physical exercise per week. Determination of weight, 
height, waist circumference (WC), hip circumference (HC), and blood pressure (BP) 
were performed by the same physician for all patients. Waist-to-hip ratio (WHR) was 
calculated and body mass index (BMI) was determined based on the equation: body 
weight (kg)/height
2 
(m
2
). Body fat percentage was calculated based on the Deurenberg 
equation: BF% = 1.20 * BMI + 0.23 * age - 10.8 * sex - 5.4. Each woman participant 
was submitted to two BP measurements, with the same instrument, 5 min apart after 
10 min of rest. BP was calculated by taking into account the mean of two 
measurements. Interviews and measurements were accomplished under similar 
circumstances and at the same time in the morning (8 –9.30 am) and.  The study 
protocol followed the ethical guidelines of the Declaration of Helsinki. All 
participants gave an informed consent before enrollment in the study. 
Selection of cases  
Seventy-two women suffering from SH (TSH level higher than 5 κIU/L measured at 
least twice in independent determinations) and who were not receiving L-T4 
treatment before the baseline visit. Both patients and controls were enrolled by Dr T. 
Stratigou. Hashimoto’s thyroiditis (HT) was diagnosed based on elevated levels of 
anti-thyroglobulin (anti-TG) and/or anti-thyroid peroxidase (anti-TPO) in serum 
and/or the presence of heterogeneous echogenicity as observed by thyroid 
ultrasonography (US).  
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Selection of control participants 
The control group was randomly selected among women who were healthy subjects 
and came for an annual check-up examination. For every eligible patient with SH, an 
attempt was made to randomly identify a control as closely as possible in time (±1 
month) and matched to patients on age (± 5 years). In total, 72 women control 
participants without any known disease involving any thyroid disease were included 
in the study. Circulating TSH, fT4, fT3, anti-TG and anti-TPO were measured and HT 
was excluded also by thyroid US. 
Exclusion criteria  
The exclusion criteria comprised age less than 18 and older than 75 years old; any 
medications that could cause thyroid dysfunction; previous thyroidectomy; 
hypertension, CVD, renal or hepatic disease; autoimmune or endocrine disorders; 
muscular, neurologic or psychiatric disorders; cancer; pregnancy and post-partum 
period; anti-lipidemic drugs; arduous physical activity or sports activity; and infection 
at the chronic period of blood drawn. All subjects were on an unrestricted diet.  
Laboratory determinations  
All blood draws were performed early in the morning after 12 hours of fasting.  
Serum thyroid parameters (TSH, fT3, fT4, T3, T4, anti-TG and anti-TPO) and insulin 
were performed using electro-chemiluminescent immunoassays (Cobas, Roche 
Diagnostics Corporation, Indianapolis, Indiana, USA). Glucose and lipid parameters 
(total cholesterol, LDL-C, HDL-C, triglycerides) were determined using an automated 
analyzer (Roche Diagnostics Corporation, Indianapolis, Indiana, USA). Homeostasis 
model assessment score of insulin resistance (HOMA-IR) was derived from the 
formula: fasting serum insulin (κU/ml) x fasting serum glucose (mmol/l)/22.5.  
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Statistical analysis 
The statistical analysis of the data was performed using IBM-SPSS® version 24 for 
Windows. In the beginning, data were assessed through simple cross-tabulations and 
by using ρ2 test for categorical variables, t-test for normally distributed variables, and 
Mann-Whitney U for not normally distributed variables. Normality hypothesis was 
tested by using the Shapiro-Wilk test. Spearman correlation coefficients were used as 
measurements of correlation for continuous variables. Multiple binary logistic 
regression analysis was employed to identify whether age of menarche, expressed as 
quartiles, is independently associated with risk of SH (dependent variable), adjusting 
for matching factors and significant clinical parameters found in univariate analyses. 
For logistic regression analysis, transformation in quartiles was performed for 
continuous variables not normally distributed. A two-sided P value of less than 0.05 
was considered significant. Bases on a previous clinical study [4], it was calculated 
that a total sample size of at least 140 women is needed to achieve 98% power at the 
0.05 level of significance in order to detect a 5-6% difference in age at menarche 
between groups.  
Results 
Clinical and laboratory biomarkers in SH cases and controls 
Descriptive categorical features and continuous clinical parameters including patient 
history information, somatometric, metabolic, thyroid, and blood pressure and lipid 
factors of all participants are presented in Tables 1 and 2. In comparison to controls, 
women with SH presented similar educational level, smoking history and physical 
exercise. (Table 1, p>0.05). However, cases tended to present a more frequent 
diagnosis of thyroid autoimmunity (p<0.001). Moreover, alcohol and coffee 
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consumption were significantly higher in patients than controls (p=0.03 and p=0.01 
respectively). 
As expected, women with SH had significantly higher levels of TSH, anti-TG and 
anti-TPO antibodies as seen in figures 1,2,3 and almost similar levels of total T3, free 
T3, free T4 (Table 2). Only total T4 was significantly lower in patients than controls 
(p<0.001). Regarding somatometric variables, women with SH presented lower hip 
circumference than controls (Fig.4, p<0.05), and BMI was slightly different between 
cases and controls (Fig.5, p=0.08). BP parameters were similar for both groups. 
Comparison of metabolic profiles revealed that women with SH showed significantly 
higher insulin levels and HOMA-IR score than controls (Fig.6, p<0.001). Also, they 
presented significantly higher concentrations of total cholesterol, LDL-C and 
triglycerides (p<0.05) but not HDL-C (p=0.35).  
Comparison of reproductive factors between SH cases and controls 
26.4% of women had their menarche until the age of 12 years and 56.9% were 
postmenopausal. Specifically, 38 women with SH and 44 controls were at menopause 
(Fig.7). Women with SH presented an earlier age at menarche than controls as seen in 
figure 8 (p<0.001). Women with SH became menopausal later than controls, but the 
difference was not significant (p=0.55, Fig.9). Interestingly, SH cases exhibited a 
significantly older age at first pregnancy (p=0.04, Fig.10) and significantly smaller 
number of full-time pregnancies (p=0.04) than controls. The duration of reproductive 
years, as far as it concerns the menopausal group, showed a nearly significant 
difference between cases and controls (p=0.07, Fig.11). Compared to controls, women 
with SH did not differ in terms of menses and period duration, parity (Fig.12) and 
lactation (Fig.13), (Table 3, p>0.05). The use of Hormone Replacement Therapy 
(HRT) was the same for both cases and controls (Table 3, Fig.14, p=1.00). Regarding 
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the use of oral contraceptives (OC) or combined use of OC and HRT, there weren’t 
any statistically significant differences (Table 3, Fig.15, 16, p>0.05). 
Correlations of age at menarche with somatometric, metabolic, thyroid 
cardiovascular parameters and reproductive factors  
As showed in Table 4, in all study women, age at menarche was positively correlated 
with weight, BMI, WC, WHR, fat mass, free fat mass, fat percentage, DBP, total T4, 
glucose and HDL-C. Age at menarche presented negative correlations with TSH, anti-
TPO and reproductive years. In particular, cases with SH exhibited a similar pattern 
of correlations but with the exception of WC, WHR, free fat mass, DBP, TSH, total 
T4, anti-TPO and HDL-C (p>0.05). Additionally, there were positive correlations 
with anti-TG, HOMA-IR, triglycerides and total cholesterol.  In controls, there were 
positive correlations of age at menarche with weight, BMI, waist circumference, 
WHR, fat mass, free fat mass, fat percentage, anti-TG, HOMA-IR, glucose, 
triglycerides, HDL-C. Moreover, controls presented negative associations with 
reproductive years, number of full-term pregnancies, HRT and a positive one with age 
at first pregnancy (p<0.05).  
Age at menarche is independently associated with SH 
Table 5 portrays multiple logistic regression-derived adjusted odds ratios (OR) and 
95% confidence intervals (CI) for associations of SH in relation to age, date of 
diagnosis (matching factors), age at menarche, BMI, hip circumference, thyroid 
autoimmunity, HOMA-IR and alcohol consumption. There was statistically 
significant evidence that earlier age at menarche expressed by quartiles was 
associated with SH, before and after adjusting for the abovementioned parameters 
(OR=0.22, 95% CI 0.11 – 0.44, p<0.001). Regarding BMI, an individual with 1kg/m2 
more had about 1.21 times more likely the risk to develop SH than someone with 
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normal BMI (OR=1.21, 95% C.I. 1.02 – 1.43, p=0.03). Regarding hip circumference, 
a woman with 1 quartile more in HC presented with lower risk of SH (OR=0.41, 95% 
C.I. 0.26 – 0.65, p<0.001). There is also strong and statistically significant evidence 
that thyroid autoimmunity, specifically Hashimoto’s thyroiditis, is associated with 
increased risk of SH. Interestingly, controlling for other parameters, an individual 
who consumes more alcohol had about 2.12 times more likely the risk to develop SH 
(OR=2.12, 95% C.I. 1.37 – 3.47, p<0.001). Finally, HOMA-IR score was not 
associated with SH risk (p=0.12).  
Discussion 
To the best of our knowledge, this is the first study showing that early age at 
menarche was independently associated with SH risk. This thesis shows that women 
with delayed menarche present a decreased risk of SH. This thesis also confirms the 
strong association between thyroid autoimmunity and higher BMI with SH risk, as 
observed in many studies [3, 5]. However, we did not find any associations between 
other reproductive factors, such as lactation, parity, age at menopause and at first 
birth, full-term pregnancies, menopausal status, reproductive years, menses and 
period duration, use of oral contraceptives, HRT and exogenous use of hormones with 
SH risk.  
It is well known that early age at menarche has been linked to several other disease 
states, such as metabolic syndrome, CVD, diabetes mellitus (DM) type 2, decreased 
bone mineral density, pre-eclampsia and breast cancer [7-9]. Nowadays, the age of 
menarche is decreasing due to many parameters, such as style of living, diet, socio-
economic and environmental factors, and educational level [10]. Women with higher 
socio-economic profiles presented lower age at menarche in contrast to those who 
were settled in low-income or rural areas with lower educational level [11]. Puberty is 
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a significant hormonal milestone in a woman’s life that is characterized by alterations 
in growth hormone, hypothalamus-pituitary-gonadal (HPG) axis, gonadotropins, 
luteinising hormone, follicle-stimulating hormone, estrogens and insulin growth 
factor- Ι [12,13].  
Whilst it is unlikely that age at menarche per se in a causal determinant for SH, it 
could be a marker of an underlying pathway that confers an elevated risk. It is 
possible that early menarche and early exposure to estrogens trigger thyroid 
autoimmunity in general. It is well-known that autoimmune diseases, including 
thyroid autoimmunity, are more frequent in women than men (Female to Male Ratio 
5:1) [14]. Indeed, early age at menarche (age 12 or younger) was strongly associated 
with a risk of Systemic Lupus Erythematosus (SLE) in big cohorts like NHS and 
NHSII [15]. Estrogen receptors are expressed in the majority of immune cells; 
nevertheless, their effects depend on receptor type and could be complicated. 
Estrogen may influence antibody-mediated immunity, including the suppression of B-
cell maturation [16].  Estrogens play a critical role in B-cell maturation and may have 
an aftereffect on the breakdown of immune tolerance observed in autoimmune 
disorders [15].  
However, the association between early menarche and SH was independent from 
thyroid autoimmunity; therefore, there might be other more complex factors playing a 
role. The role of estrogens and estrogen receptors in thyroid autoimmunity and 
progression to SH, may be explained also by early menarche. Estrogen receptors and 
earlier exposure to estrogens may influence the initiation and progression of thyroid 
autoimmunity. In vitro studies have shown that estrogen significantly increased 
proliferation, inflammation and invasive properties of thyroid cancer cell lines [5, 17-
19]. Finally, another mechanism may comprise the fact that early menarche may be 
Institutional Repository - Library & Information Centre - University of Thessaly
04/06/2020 22:21:32 EEST - 137.108.70.13
[13] 
 
associated with body fatness, insulin resistance and cardio-metabolic risk factors in 
the majority of Western studies [20, 21]. The abovementioned factors are also 
associated with SH risk [5, 22-25].  
This thesis presents many methodologic strengths. A properly powered study was 
implemented which was sufficient to replicate prior established associations of the 
study parameters with SH risk and to produce new statistically significant associations 
with age at menarche. Finally, to minimize the chances of potential uncontrolled 
exposures, this thesis included controls who were carefully matched to cases and 
drawn from the same study population.   
However, this thesis presents some limitations to take into consideration. First of all, 
it was impossible to collect any somatometric data at childhood, as well as follow-up 
data, that may affect menarcheal age and negative health outcome of later life. 
Secondly, the cross-sectional nature of this thesis impedes conclusions as per the 
existence of a causal relationship, despite the fact that menarcheal age precedes SH. 
Third, menarcheal age was reported by recall; nevertheless, menarche is an important 
event in a woman’s life, therefore, it is reliable throughout many years [26]. The case-
control design cannot demonstrate causality but may raise reliable hypotheses to be 
bolstered and extended in future prospective and longitudinal studies. Although 
confounding variables were properly controlled for by employing standard statistical 
procedures, residual confounding by other undetermined variables and hormones is 
always a possibility that may be explored in future larger studies. Finally, another 
limitation of the thesis is the moderate sample size, which eventually was sufficient to 
replicate previous associations of risk factors with SH risk.  
In conclusion, this thesis showed an independent association of early menarche with 
an increased risk of SH. Although it is still unclear how hormonal and reproductive 
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factors are related to SH, this thesis raises reliable hypothesis regarding the interplay 
of early exposure to estrogens with SH risk. Further larger prospective studies and 
genetic research of the association of reproductive factors with SH are needed. More 
investigation is warranted to explain the greater prevalence of SH amid women.  
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Table 1   Descriptive Categorical Features of subclinical hypothyroidism cases (n=72) and control 
participants (n=72). 
Categorical Variables 
 
Cases (n=72) 
N (%) 
Controls (n=72) 
N (%) 
p-value 
Education (years)   0.74 
   6 8 (11.1) 4 (5.6)  
   9 10 (13.9) 8 (11.1)  
  12 32 (44.4) 36 (50.0)  
>12 22 (30.6) 24 (33.4)  
Smoking history   0.50 
  Non-Smoker 40 (55.6) 36 (50.0)  
  Ex-Smoker 14 (19.4) 20 (27.8)  
  Current Smoker 18 (25.0) 16 (22.2)  
Alcohol consumption   0.03 
  Never 8 (11.1) 8 (11.1)  
  Rarely (1-2 glasses per month) 12 (16.7) 24 (33.3)  
  Weekly (1-2 glasses per week) 24 (33.3) 28 (38.9)  
  Weekly (3-4 glasses per week) 20 (27.8) 8 (11.1)  
Coffee consumption   0.01 
 Never 4 (5.6) 0 (0.0)  
 Few times per month 10 (13.9) 8 (11.1)  
 Few times per week 6 (8.3) 20 (27.8)  
 Daily 52 (72.2) 44 (61.1)  
Physical activity (≥ 2 hours/week) 10 (13.9) 16 (22.2) 0.19 
Presence of thyroid autoimmunity 
(yes, %) 
21 (29.2) 4 (5.6) <0.001 
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Table 2 Baseline Continuous Parameters of subclinical hypothyroidism cases (n=72) and control 
participants (n=72). 
 
Continuous variables Cases (n=72) 
Mean (SD) 
Controls (n=72) 
Mean (SD) 
 p-value 
 
Reference 
range  
Age, years 48.6 (15.6) 49.9 (14.3) 0.74 - 
Weight, kg 67.8 (11.4) 64.6 (8.2) 0.05 - 
Height, m 1.64 (0.04) 1.64 (0.04) 0.87 - 
BMI, kg/m
2
 25.2 (4.0) 24.0 (3.1) 0.08 - 
Waist circumference, cm 80.9 (11.6) 83.6 (10.1) 0.15 - 
Hip circumference, cm 91.1 (10.5) 95.6 (7.3) 0.01 - 
WHR 0.9 (0.08) 0.9 (0.06) 0.09 - 
Fat % 35.9 (5.9) 34.9 (4.9) 0.22 - 
Fat mass, kg 24.8 (7.5) 22.8 (5.6) 0.06 - 
Free fat Mass, kg 42.9 (5.2) 41.8 (3.8) 0.20 - 
SBP, mmHg 128.4 (18.8) 125.8 (11.4) 0.27 - 
DBP, mmHg  80.1 (12.1) 79.7 (6.8) 0.84 - 
Mean arterial BP
∂
, mmHg 96.2 (13.9) 95.1 (8.1) 0.47 - 
TSH, κIU/mL 8.5 (1.8) 2.7 (0.7) <0.001 0.27 – 4.2 
free T3, pg/mL 3.1 (0.8) 3.1 (0.6) 0.94 2.0 – 4.4 
free T4, ng/mL  1.4 (0.4) 1.5 (0.3) 0.09 0.8 – 2.0 
Total T3, ng/mL 1.3 (0.3) 1.3 (0.3) 0.45 0.8 – 2.0 
Total T4, κg/dL 8.0 (1.8) 11.1 (1.3) <0.001 5.1 – 14.1 
Anti-TG Ab, IU/mL 56.5 (37.7) 34.5 (29.8) <0.001 0 - 115 
Anti-TPO Ab, IU/mL 26.4 (23.7) 13.1 (7.5) <0.001 0 - 34 
Glucose, mg/dL 83.5 (11.2) 80.3 (10.9) 0.09 74 - 106 
Insulin, κU/mL 22.2 (5.1) 19.3 (3.1) <0.001 2.6 – 24.9 
HOMA-IR score 4.7 (1.6) 3.9 (0.9) <0.001 - 
Total cholesterol, mg/dL 209.7 (14.7) 196.8 (14.9) <0.001 140 - 220 
Triglycerides, mg/dL 138.0 (51.2) 86.2 (24.5) <0.001 <200 
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HDL-C, mg/dL 56.7 (6.7) 58.0 (6.8) 0.35 ♀: 45 - 65 
LDL-C, mg/dL 137.1 (11.5) 129.2 (12.4) 0.001 <159 
∂
Mean Arterial BP= (2*DBP+ SBP)/3  
Reproductive years = Age at menarche – Age at menopause 
Ab: antibody; BP: blood pressure; BMI: Body Mass Index; DBP: Diastolic Blood Pressure; HDL-C: High-density lipoprotein 
cholesterol; HOMA: Homeostasis model assessment score of insulin resistance; LDL-C: Low-density  lipoprotein cholesterol; 
SBP: Systolic Blood Pressure; SD: standard deviation; T3: Triiodothyronine; T4: Thyroxine; TG: Thyroglobulin; TPO: 
Thyroid peroxidase; TSH: Thyroid stimulating hormone; WHR: Waist-to-hip ratio 
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Table 3   Reproductive factors of subclinical hypothyroidism cases (n=72) and control participants 
(n=72). 
Reproductive factors 
 
Cases (n=72) 
 
Controls (n=72) 
 
p-value 
Continuous variables Mean (SD) Mean (SD)  
Age at menarche, years 12.6 (1.2) 13.3 (0.8) <0.001 
Age at menopause, years (n=38) 
45.0 (2.7) 
(n=44) 
44.3 (3.1) 
0.55 
Reproductive years (n=38) 
32.2 (3.0) 
(n=44) 
31.0 (3.3) 
0.07 
Menses duration, days 29.1 (1.9) 28.6 (1.7) 0.14 
Period duration, days 5.07 (0.51) 5.08 (0.44) 0.84 
Age at first pregnancy, years 29.6 (5.22) 28.27 (4.71) 0.04 
Full-term pregnancies 1.75 (0.49) 2.02 (0.63) 0.04 
Categorical Variables N (%) N (%)  
Use of oral contraceptives  
yes, %) 
7 (9.7) 6 (8.3) 0.77 
Hormone Replacement Therapy  
(yes, %) 
3 (4.2) 3 (4.2) 1.00 
Exogenous use of hormones* (yes, 
%) 
10 (13.9) 9 (12.5) 0.81 
Parity (yes, %) 40 (55.6) 44 (61.1) 0.50 
Lactation (yes, %) 23 (31.95) 28 (38.89) 0.66 
Menopausal (yes, %) 38 (52.8) 44 (61.1) 0.31 
*Exogenous use of hormones: Hormone Replacement Therapy & Oral Contraceptives 
 
 
 
 
 
 
 
 
 
 
Institutional Repository - Library & Information Centre - University of Thessaly
04/06/2020 22:21:32 EEST - 137.108.70.13
[22] 
 
Table 4 Correlations of study variables with age at menarche 
 
 
 
Variables 
 
 
Whole Population 
n=144 
 
r                 p 
Cases with SH 
n=72 
 
r                p 
Controls 
n=72 
                                    
r                   p 
Age  0.09 0.30 0.14 0.25 -0.06 0.60 
Height 0.09 0.26 0.14 0.24 0.05 0.65 
Weight 0.37 <0.001 0.30 0.01 0.67 <0.001 
Body Mass Index 0.34 <0.001 0.30 0.01 0.60 <0.001 
Waist circumference 0.29 <0.001 0.17 0.16 0.40 0.001 
Hip circumference 0.08 0.35 0.002 0.99 0.05 0.66 
WHR 0.27 0.001 0.18 0.14 0.51 <0.001 
Fat % 0.33 <0.001 0.29 0.02 0.49 <0.001 
Fat mass 0.35 <0.001 0.31 0.008 0.58 <0.001 
Free fat Mass 0.27 0.001 0.20 0.09 0.45 <0.001 
SBP 0.07 0.44 0.17 0.15 -0.06 0.59 
DBP 0.23 0.001 0.22 0.06 0.23 0.06 
Mean arterial BP 0.12 0.15 0.18 0.14 0.05 0.68 
TSH -0.25 0.003 0.08 0.52 -0.05 0.68 
free T3 0.01 0.92 0.08 0.53 -0.06 0.63 
free T4 0.16 0.05 0.14 0.23 0.22 0.85 
Total T3  0.03 0.75 0.03 0.82 -0.003 0.98 
Total T4 0.21 0.01 -0.15 0.22 0.01 0.95 
Anti-TG Ab 0.15 0.07 0.29 0.01 0.26 0.03 
Anti-TPO Ab -0.20 0.02 -0.18 0.13 0.03 0.79 
HOMA-IR 0.15 0.08 0.24 0.04 0.25 0.03 
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Glucose 0.21 0.01 0.31 0.01 0.25 0.04 
Insulin 0.08 0.32 0.15 0.21 0.21 0.08 
Triglycerides 0.03 0.72 0.26 0.02 0.32 0.007 
Total Cholesterol 0.13 0.12 0.31 0.008 0.21 0.07 
LDL-C -0.04 0.14 0.12 0.32 -0.06 0.59 
HDL-C 0.24 0.004 0.16 0.19 0.35 0.003 
Age at menopause -0.18 0.10 -0.09 0.60 -0.28 0.07 
Reproductive years -0.49 <0.001 -0.51 <0.001 -0.35 0.02 
Menses duration -0.10 0.22 -0.16 0.17 0.07 0.54 
Period duration -0.05 0.55 -0.09 0.47 -0.05 0.66 
Age at first pregnancy -0.02 0.89 -0.19 0.22 0.40 0.01 
Full-term pregnancies -0.13 0.25 -0.06 0.71 -0.41 0.01 
Ab: antibody; DBP: Diastolic Blood Pressure; HDL-C: High-density lipoprotein cholesterol; HOMA: 
Homeostasis model assessment score of insulin resistance; LDL-C: Low-density lipoprotein cholesterol; 
SBP: Systolic Blood Pressure; SD: standard deviation; SH: Subclinical Hypothyroidism; T3: 
Triiodothyronine; T4: Thyroxine; TG: Thyroglobulin; TPO: Thyroid peroxidase; TSH: Thyroid stimulating 
hormone; WHR: Waist-to-hip ratio 
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Table 5 Association of age at menarche, autoimmune thyroid disease, BMI, Hip 
Circumference and HOMA-IR with risk of subclinical hypothyroidism in 72 cases with 
subclinical hypothyroidism and in 72 controls matched on age and date of diagnosis; 
multiple logistic regression-derived, adjusted odds ratios (OR‡) and 95% confidence 
intervals (95% CI) 
 
Variables 
 
 
Category or Increment 
 
p-value 
 
OR 
 
   95% CI 
Age at menarche 1 quartile more  <0.001 0.22 0.11 – 0.44 
BMI 1 kg/ m
2
 more 0.03 1.21 1.02 – 1.43 
Hip Circumference  1 quartile more <0.001 0.41 0.26 – 0.65 
Thyroid Autoimmunity Yes versus No  <0.001 45.27 5.84 – 350.79 
HOMA – IR  1 SD more 0.12 1.66 0.89 – 3.11 
Alcohol consumption 1 category of alcohol 
consumption more 
0.001 2.12 1.37 – 3.47 
‡ adjusted for age and date of diagnosis and blood draw (matching factors) 
SD: standard deviation 
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Fig.1 Box plots of TSH in 72 cases with subclinical hypothyroidism (8.5±1.8) and 72 
controls (2.7±0.7, p<0.001). 
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Fig.2 Box plots of anti-TG antibodies in 72 cases with subclinical hypothyroidism 
(56.5±37.7) and 72 controls (34.5±29.8, p<0.001). 
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Fig.3 Box plots of anti-TPO antibodies in 72 cases with subclinical hypothyroidism 
(26.4±23.7) and 72 controls (13.1±7.5, p<0.001). 
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Fig.4 Box plots of hip circumference in 72 cases with subclinical hypothyroidism 
(91.1±10.5) and 72 controls (95.6±7.3, p=0.01). 
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Fig.5 Box plots of BMI in 72 cases with subclinical hypothyroidism (25.2±4.0) and 72 
controls (24.0±3.1, p=0.08). 
 
Institutional Repository - Library & Information Centre - University of Thessaly
04/06/2020 22:21:32 EEST - 137.108.70.13
[30] 
 
 
Fig.6 Box plots of HOMA-IR in 72 cases with subclinical hypothyroidism (4.7±1.6) and 
72 controls (3.9±0.9, p<0.001). 
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Fig.7 Cases with subclinical hypothyroidism did not differ in terms of menopausal status 
compared to controls (52.8% vs. 61.1%. p=0.31). 
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Fig. 8 Box plots of age at menarche in 72 cases with subclinical hypothyroidism 
(12.6±1.2) and 72 controls (13.3±0.8, p<0.001). 
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Fig. 9 Box plots of age at menopause in 38 cases with subclinical hypothyroidism 
(45.0±2.7) and 44 controls (44.3±3.1, p=0.55). 
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Fig.10 Box plots of age at first pregnancy in 40 cases with subclinical hypothyroidism 
(29.6±5.22) and 44 controls (28.3±4.71, p=0.04).  
 
Institutional Repository - Library & Information Centre - University of Thessaly
04/06/2020 22:21:32 EEST - 137.108.70.13
[35] 
 
 
Fig.11 Box plots of reproductive years in 38 cases with subclinical hypothyroidism 
(32.2±3.0) and 44 controls (31.0±3.3, p=0.07). 
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Fig.12 Cases with subclinical hypothyroidism did not differ in terms of parity compared 
to controls (55.6% vs. 61.1%. p=0.50). 
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Fig.13 Cases with subclinical hypothyroidism did not differ in terms of lactation 
compared to controls (31.95% vs. 38.89%. p=0.66). 
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Fig.14 Cases with subclinical hypothyroidism did not differ in terms of use of Hormone 
Replacement Therapy compared to controls (4.2% vs. 4.2%. p=1.00). 
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Fig.15 Cases with subclinical hypothyroidism did not differ in terms of use of oral 
contraceptives compared to controls (9.7% vs. 8.3%. p=0.77). 
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Fig.16 Cases with subclinical hypothyroidism did not differ in terms of Exogenous Use 
of Hormones compared to controls (13.9% vs. 12.5%. p=0.81). 
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